Q1 FY14 Results and Analysis Pharmaceuticals Industry Growth Pangs

Can't see the pictures? Select Display Images option shown above. Add info@investorsareidiots.com to your address book to ensure delivery of our emails to your in-box. View this email outside your inbox

13th August 2013

Q1 FY14 Results and Analysis   Hi Promofree Pharmaceuticals Industry Growth Pangs On an overall basis, Pharma companies have shown a mixed bag of results in the first quarter of FY 14. Headwinds in the form of drug pricing policy in India and heavy competition in the export market has impacted both topline and bottomline. However companies such as Sun Pharma and CIPLA have managed to grow at a healthy pace with improvement in margins. click here to read full analysis Arjun Parthasarathy www.investorsareidiots.com arjun@investorsareidiots.com Information herein is believed to be reliable but the editor of Investors are Idiots.com Arjun Parthasarathy does not warrant its completeness or accuracy. Opinions and estimates are subject to change without notice. This information is not intended as an offer or solicitation for the purchase or sale of any financial instrument. The financial markets are inherently risky and it is assumed that those who trade these markets are fully aware of the risk of real loss involved. Unauthorized copying, distribution or sale of this publication is strictly prohibited. The author of the articles may have investments in instruments that are the subject of the articles. © InvestorsAreIdiots.com. All rights reserved. Not interested in receiving emails from us? Click to unsubscribe.